Hormonotherapy of advanced prostate cancer

P. Pronzato, M. Rondini

Research output: Contribution to journalArticlepeer-review


More than two decades of studies on hormonal treatment of Prostate Cancer are briefly reviewed. Recent American Society of Clinical Oncology recommendations have pointed the major issues faced in randomized clinical trials and meta-analyses. Androgen ablation remains the mainstay of treatment for advanced stages, while Docetaxel based chemotherapy is becoming the standard in hormonorefractory tumors and targeted therapies are approaching.

Original languageEnglish
JournalAnnals of Oncology
Issue numberSUPPL. 4
Publication statusPublished - May 2005


  • Hormonotherapy
  • Metastatic
  • Prostate cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Hormonotherapy of advanced prostate cancer'. Together they form a unique fingerprint.

Cite this